APR 11, 2017 10:05 AM PDT

Battling the Cancer Takeover of Immune Cells

WRITTEN BY: Kara Marker

An overwhelming majority of cancer deaths are in some way connected to metastasis even though the immune system is rather effective at scouring the bloodstream for traveling cancer cells. This is because cancer cells have found a way around the ever-watching eye of the immune system, by seizing control of myeloid-derived suppressive cells (MDSCs) from the bone marrow.

Credit: Phil Jones, Senior Augusta University Photographer

"There is a very intricate balance in the immune system that is usually anti-tumorigenic, meaning it eliminates tumors, but in some cases, if this balance is altered, these cells may actually help tumors grow and develop into full-blown metastatic disease," explained Hasan Korkaya, PhD from the Medical College of Georgia at Augusta University.

MDSCs are conveniently capable of suppressing the immune response. While immune regulation is vital in some situations, cancer cells take advantage of MDSCs, using their “powers” for “evil” instead of “good.” MDSCs are found in high levels in mouse models and humans with cancer, and researchers from the Medical College of Georgia are working on unveiling the role of MDSCs in cancer metastasis.

Cancer cells secrete cytokines just like the immune system to communicate with MDSCs, and two different types of MDSCs are evidently useful to the cancer agenda.

  • Monocytic cells facilitate the tumor cell transition into a stem cell-like state to enable them to leave the primary tumor, enter the bloodstream, travel to a new area of the body, and set up camp

  • Granulocytic cells expedite the transition back to cancer cells and the multiplication process to build a new population of tumors

The therapeutic plan of attack is to “re-school” MDSCs to shift their loyalty back to the immune system, attacking cancer cells instead of protecting them. Additionally, researchers are interested in identifying and targeting cytokines used by cancer cells to communicate with MDSCs, literally killing the messenger.

The present study was published in the journal Nature Communications.

Source: Medical College of Georgia at Augusta University

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 15, 2019
Immunology
SEP 15, 2019
When the Immune System Makes a Mistake: Autoimmunity
A team from Scripps Research has found a molecular cause of a group of rare autoimmune disorders in which the immune system attacks the body's healthy cells....
SEP 15, 2019
Immunology
SEP 15, 2019
Unconventional T Cells
Spondyloarthritis is one of the most common types of chronic joint inflammation affecting nearly 1-2 percent of the Western population. Scientists report that rare populations of unconvention...
SEP 15, 2019
Health & Medicine
SEP 15, 2019
The Role of the Gut-Lung Axis in the Development of Tuberculosis
Observations of the human microbiota date back as far as the 1680s when Antonie van Leeuwenhoek noted significant differences in the types of bacteria from...
SEP 15, 2019
Drug Discovery
SEP 15, 2019
Glowing Tumors Reveal How Immunotherapeutics Work
In a study published in the Journal of Clinical Investigation, researchers used positron emission tomography (PET) scans to examine how an immunotherapy dr...
SEP 15, 2019
Microbiology
SEP 15, 2019
Healthy Fat From a Beneficial Microbe May Help us Relieve Stress
We may one day be able to use a 'stress vaccine' to ward off the damage caused by traumatic events....
SEP 15, 2019
Drug Discovery
SEP 15, 2019
Novel Treatments for Auto-immune Disorders
A recent research study examined a library of almost 300,000 small molecules to search for a molecule that may be a potential target for the human GMP-AMP ...
Loading Comments...